Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTENGAN, Fatima Mitiko
dc.contributor.authorIBRAHIM, Karim Yakub
dc.contributor.authorDANTAS, Bianca Peixoto
dc.contributor.authorMANCHIERO, Caroline
dc.contributor.authorMAGRI, Mariana Cavalheiro
dc.contributor.authorBERNARDO, Wanderley Marques
dc.date.accessioned2017-02-16T12:44:47Z
dc.date.available2017-02-16T12:44:47Z
dc.date.issued2016
dc.description.abstractBackground: Studies have shown that the immunosuppression induced by the human immunodeficiency virus (HIV) accelerates the natural history of liver disease associated with hepatitis C virus (HCV), with 3- to 5-fold higher odds of coinfected individuals developing cirrhosis. However, estimates of the seroprevalence of hepatitis C among people living with HIV/acquired immune deficiency syndrome (AIDS) (PLHA) in Latin America and the Caribbean (LAC) are widely variable. Methods: We performed a systematic review to estimate the seroprevalence of HCV among PLHA. We searched studies on HIV and HCV infections in LAC included in the PubMed, LILACS and Embase databases in December of 2014 with no time or language restrictions. The following combinations of search terms were used in the PubMed and Embase databases: (HIV OR Acquired Immunodeficiency Syndrome Virus OR AIDS OR HTLV OR Human Immunodeficiency Virus OR Human T Cell) AND (HCV OR HEPATITIS C OR HEPATITIS C VIRUS OR HEPACIVIRUS) AND (name of an individual country or territory in LAC). The following search terms were used in the LILACS database: (HIV OR AIDS OR Virus da Imunodeficiencia Humana) AND (HCV OR Hepatite C OR Hepacivirus). An additional 11 studies were identified through manual searches. A total of 2,380 publications were located, including 617 duplicates; the remaining articles were reviewed to select studies for inclusion in this study. Results: A total of 37 studies were selected for systematic review, including 23 from Brazil, 5 from Argentina, 3 from Cuba, 1 from Puerto Rico, 1 from Chile, 1 from Colombia, 1 from Mexico, 1 from Peru and 1 from Venezuela. The estimated seroprevalence of HCV infection varied from 0.8 to 58.5 % (mean 17.37; median 10.91), with the highest in Argentina and Brazil and the lowest in Venezuela and Colombia. Conclusions: Investigation of HCV infection among PLHA and of HIV infection among people living with HCV is highly recommended because it allows for better follow up, counseling and treatment of HIV/HCV-coinfected patients. Future studies with larger sample sizes are needed in both South and Central America to understand and address the risk factors associated with the acquisition of infection.
dc.description.indexMEDLINE
dc.identifier.citationBMC INFECTIOUS DISEASES, v.16, article ID 663, 8p, 2016
dc.identifier.doi10.1186/s12879-016-1988-y
dc.identifier.issn1471-2334
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/17904
dc.language.isoeng
dc.publisherBIOMED CENTRAL LTD
dc.relation.ispartofBMC Infectious Diseases
dc.rightsopenAccess
dc.rights.holderCopyright BIOMED CENTRAL LTD
dc.subjectHepatitis C
dc.subjectHCV
dc.subjectHIV
dc.subjectCoinfection
dc.subjectSeroprevalence
dc.subjectLatin America
dc.subjectCaribbean
dc.subject.otherhuman-immunodeficiency-virus
dc.subject.otherinjection-drug users
dc.subject.otherhiv-infected individuals
dc.subject.othersexually-transmitted-diseases
dc.subject.otheractive antiretroviral therapy
dc.subject.otherrisk-factors
dc.subject.othergenotype characterization
dc.subject.othervirological responses
dc.subject.otherepidemiologic aspects
dc.subject.otherhiv/hcv coinfection
dc.subject.wosInfectious Diseases
dc.titleSeroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus15
hcfmusp.contributor.author-fmusphcFATIMA MITIKO TENGAN
hcfmusp.contributor.author-fmusphcKARIM YAQUB IBRAHIM
hcfmusp.contributor.author-fmusphcBIANCA PEIXOTO DANTAS
hcfmusp.contributor.author-fmusphcCAROLINE MANCHIERO
hcfmusp.contributor.author-fmusphcMARIANA CAVALHEIRO MAGRI
hcfmusp.contributor.author-fmusphcWANDERLEY MARQUES BERNARDO
hcfmusp.description.articlenumber663
hcfmusp.description.volume16
hcfmusp.origemWOS
hcfmusp.origem.pubmed27829381
hcfmusp.origem.scopus2-s2.0-84994894970
hcfmusp.origem.wosWOS:000387728000002
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAbdala N, 2003, INT J STD AIDS, V14, P697, DOI 10.1258/095646203322387965
hcfmusp.relation.referenceFarias AA, 2013, T ROY SOC TROP MED H, V107, P432, DOI 10.1093/trstmh/trt043
hcfmusp.relation.referenceAlfonso AP, 2008, REV CUBA MED TROP, V60, P141
hcfmusp.relation.referenceBoyle MH, 1998, EVIDENCE BASED MENTA, V1, P37, DOI 10.1136/EBMH.1.2.37
hcfmusp.relation.referenceBrunetta DM, 2013, BRAZ J INFECT DIS, V17, P654, DOI 10.1016/j.bjid.2013.03.010
hcfmusp.relation.referenceCarmo RA, 2008, BRAZ J INFECT DIS, V12, P173, DOI 10.1590/S1413-86702008000300003
hcfmusp.relation.referenceBello Corredor M, 2005, REV CUBA MED TROP, V57, P212
hcfmusp.relation.referencede Carvalho F, 2006, REV PARA MED, V20, P11
hcfmusp.relation.referencedos Santos EO, 2008, REV PARA MED, V22, P23
hcfmusp.relation.referenceEDELENYIPINTO M, 1993, MEM I OSWALDO CRUZ, V88, P305
hcfmusp.relation.referenceFainboim H, 1999, J VIRAL HEPATITIS, V6, P53, DOI 10.1046/j.1365-2893.1999.t01-1-6120135.x
hcfmusp.relation.referenceTÁVORA Lara Gurgel Fernandes, 2013, Arq. Gastroenterol., V50, P277, DOI 10.1590/S0004-28032013000400007
hcfmusp.relation.referenceFOWKES FGR, 1991, BRIT MED J, V302, P1136
hcfmusp.relation.referenceFreitas SZ, 2014, REV INST MED TROP SP, V56, P517, DOI 10.1590/S0036-46652014000600011
hcfmusp.relation.referenceGarten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019
hcfmusp.relation.referenceGraham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
hcfmusp.relation.referenceGreub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3
hcfmusp.relation.referenceGuimaraes R. A., 2010, Revista Brasileira de Medicina, V67, P296
hcfmusp.relation.referenceHoyos-Orrego Alvaro, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P321, DOI 10.1590/S0036-46652006000600004
hcfmusp.relation.referenceHYAMS KC, 1992, J MED VIROL, V37, P127, DOI 10.1002/jmv.1890370210
hcfmusp.relation.referenceJaspe RC, 2014, J MED MICROBIOL, V63, P1099, DOI 10.1099/jmm.0.067496-0
hcfmusp.relation.referenceLavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x
hcfmusp.relation.referenceLibrelotto CS, 2014, BRAZ J INFECT DIS, V18, P689, DOI 10.1016/j.bjid.2014.05.014
hcfmusp.relation.referenceLincoln D, 2003, HIV Med, V4, P241, DOI 10.1046/j.1468-1293.2003.00152.x
hcfmusp.relation.referenceLoney P L, 1998, Chronic Dis Can, V19, P170
hcfmusp.relation.referenceGoncales NSL, 2007, BRAZ J INFECT DIS, V11, P22, DOI 10.1590/S1413-86702007000700008
hcfmusp.relation.referenceMendes-Correa Maria Cassia J., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P15, DOI 10.1590/S0036-46652001000100003
hcfmusp.relation.referenceMoher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
hcfmusp.relation.referenceMussi ADH, 2007, ACTA TROP, V104, P116, DOI 10.1016/j.actatropica.2007.08.001
hcfmusp.relation.referenceNelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0
hcfmusp.relation.referenceOliveira AB, 2012, ARCH VIROL, V157, P2411, DOI 10.1007/s00705-012-1435-3
hcfmusp.relation.referencePando MDP, 2004, AM J TROP MED HYG, V71, P153
hcfmusp.relation.referencePavan Maria Helena P., 2003, Braz J Infect Dis, V7, P253, DOI 10.1590/S1413-86702003000400005
hcfmusp.relation.referencePereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60
hcfmusp.relation.referencePerez C, 2009, REV MED CHILE, V137, P641, DOI /S0034-98872009000500007
hcfmusp.relation.referencePerez CM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-76
hcfmusp.relation.referencePineda JA, 2005, J ANTIMICROB CHEMOTH, V55, P417, DOI 10.1093/jac/dkh555
hcfmusp.relation.referencede Carvalho FHP, 2009, REV SAUDE PUBL, V43, P133, DOI 10.1590/S0034-89102009000100017
hcfmusp.relation.referencePrins J, 2002, INT J IMPOT RES, V14, P422, DOI 10.1038/sj.ijir.3900905
hcfmusp.relation.referenceQuan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610
hcfmusp.relation.referenceQuarleri Jorge F., 2007, Acta Gastroenterologica Latinoamericana, V37, P76
hcfmusp.relation.referenceRe V, 2008, ENFERM INFEC MICR CL, V26, P423, DOI 10.1157/13125639
hcfmusp.relation.referenceRivas-Estilla AM, 2007, HEPATOL RES, V37, P311, DOI 10.1111/j.1872-034X.2007.00035.X
hcfmusp.relation.referenceRockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762
hcfmusp.relation.referenceRodriguez ME, 2005, CLIN MICROBIOL INFEC, V11, P764, DOI 10.1111/j.1469-0691.2005.01209.x
hcfmusp.relation.referenceSampaio AS, 2009, ACTUALIZADIONES SID, V17, P12
hcfmusp.relation.referenceSantos KF, 2010, REV BRAS ANAL CLIN, V42, P21
hcfmusp.relation.referenceSegurado AC, 2004, AIDS PATIENT CARE ST, V18, P135, DOI 10.1089/108729104322994829
hcfmusp.relation.referenceSherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
hcfmusp.relation.referenceSimon D, 2014, EPIDEMIOL INFECT, V142, P2616, DOI 10.1017/S0950268814000041
hcfmusp.relation.referenceSolomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85
hcfmusp.relation.referenceSoto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3
hcfmusp.relation.referenceSulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199
hcfmusp.relation.referenceTan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608
hcfmusp.relation.referenceTedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953
hcfmusp.relation.referenceThein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51
hcfmusp.relation.referenceTHOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005
hcfmusp.relation.referenceTovo Cristiane Valle, 2006, Arq. Gastroenterol., V43, P73, DOI 10.1590/S0004-28032006000200002
hcfmusp.relation.referenceTreitinger A, 1999, BRAZ J INFECT DIS, V3, P1
hcfmusp.relation.referenceVictoria MB, 2010, BRAZ J INFECT DIS, V14, P135, DOI 10.1590/S1413-86702010000200004
hcfmusp.relation.referenceReiche EMV, 2008, INT J MOL MED, V21, P387
hcfmusp.relation.referenceWHO, GLOB HLTH OBS GHO DA
hcfmusp.relation.referenceWolff FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010494
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationcb35853d-1777-4f0d-9a93-bd2aae413bf0
relation.isAuthorOfPublication9e84c99a-3058-40a7-a927-d2823f19e8ab
relation.isAuthorOfPublication7c2e7617-808c-40b0-be2a-b7a536d6b649
relation.isAuthorOfPublication115a1f7d-6756-4ba2-adf8-41b07a877ed1
relation.isAuthorOfPublicationcd1ed33e-c54c-4a07-9f7d-48f7c1e4754c
relation.isAuthorOfPublicationc86b438c-c045-42c0-bbbb-347de72d169c
relation.isAuthorOfPublication.latestForDiscoverycb35853d-1777-4f0d-9a93-bd2aae413bf0
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_TENGAN_Seroprevalence_of_hepatitis_C_virus_among_people_living_2016.PDF
Tamanho:
749.84 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03